Atlas Trials

Evaluate the Safety and Efficacy of Botulax® as Compared to Botox® in Subject With Moderate to Severe Crow's Feet Lines

Clinical trial NCT03408236 · COMPLETED

Trial details

NCT number
NCT03408236
Sponsor
Hugel
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Crow's Feet Lines
Start date
2018-01-17
Primary completion
2018-12-13
Enrollment
240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.